[1]
“PREVALENCE OF FACTOR V LEIDEN MUTATION IN IRAQI PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND ITS ASSOCIATION WITH MPN DRIVER MUTATIONS: A CROSS-SECTIONAL STUDY”, AIMCJ, vol. 3, no. 2, pp. 56–70, Aug. 2026, doi: 10.58564/AIMCJ3.2.2026.310.